TrialArthritis research & therapy2021

Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial.

Marit Stockfelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.